Abiogen is one of the top 30 pharmaceutical companies in Italy (358 employees, turnover 2016 157 M, +16%), whose production is concentrated in the Ospedaletto facility (Pisa), where injectable, ointments, oral liquid and solid products are produced, 90% of which to meet domestic demand and the rest for contract manufacturing. The company's core business is bone metabolism pathologies, including rare diseases, in particular the osteoarticular area (three quarters of turnover) with bisphosphonates (e. g. Neridronate), then dermatology, diabetes, respiratory infections. Abiogen also carries out third-party production services (CMO), a growing activity in terms of turnover, exploiting its own certified and high-level know-how and plants. Abiogen has a programme of internationalisation towards European and non-European countries.
